Why did Atossa Therapeutics Inc. (ATOS) underperform on Thursday?
Atossa Therapeutics Inc. (ATOS) shares fell 5.38% in after-hours on Thursday, July 29, 2021, and closed the daily trading at $3.69 per share. Earlier in the regular trading on Thursday, ATOS’s stock lost 1.27%. ATOS shares have fallen 10.34% over the last 12 months, and they have moved down by 5.11% in the past week. […]
Atossa Therapeutics, Inc. (ATOS) stock gains during pre-market trading. Here’s to know why?
Atossa Therapeutics, Inc. (NASDAQ: ATOS) stock declined by 27.51% at the last close while the ATOS stock price rises further by 9.09% in the pre-market trading session. Atossa Therapeutics is a clinical-stage biopharmaceutical business focused on discovering and developing new medications in unmet medical needs, with a current emphasis on breast cancer and COVID-19. Significant […]
Atossa Therapeutics Inc. (ATOS) stock soars during after-hour session. Here’s to know why?
Atossa Therapeutics Inc. (NASDAQ: ATOS) stock gained by 30.09% at last close while the ATOS stock price rises by 4.83% in the after-hours trading session. Atossa Therapeutics is a clinical-stage biopharmaceutical business specializing on oncology and infectious illnesses, with a current emphasis on breast cancer and COVID-19. Upcoming Important Event ATOS will offer a webinar […]
Atossa Therapeutics, Inc. (ATOS) stock surged in the premarket trading session; here’s why
In the pre market trading session, Atossa Therapeutics Inc. (ATOS) stock has surged by 7.27% to $2.36 at the time of writing. ATOS stock closed the previous session at $2.20 gaining 12.24%. The ATOS stock volume traded about 20.85 million shares. In the past year, ATOS stock slumped by -0.90%. While in the past week […]
Why Atossa Therapeutics (ATOS) Is Surging 38% Pre-Market?
Before the ring of the bell today, Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company, has been seeing a 30.24% jump in its stock price. At the close of the previous session, the stock was up 16.43% to close at $2.48. Over the past 5 sessions, the stock is down -8.49% while the decline […]
Let’s see how Atossa Therapeutics, Inc. (ATOS) has progressed since last night
Atossa Therapeutics, Inc. (NASDAQ: ATOS) stock was up 15.10 in the premarket after jumping close to 60% in the previous close. The company’s stock has changed by 138.40% in the past five days and 60.22% in the past three months. At the time of publication, ATOS shares are trading 213.68% higher than they did a […]
Premarket Stock Gainers
Pre-market data show Xunlei Limited (NASDAQ:XNET) is 7.89% higher at $3.28. It recently closed at $3.04, fluctuating in a day’s range from $2.94 to $3.44 and a 52-week trading range of $2.38 to $5.94. 9 Meters Biopharma Inc. (NASDAQ:NMTR) is trading at $0.9 up with 19.21 percent or 0.15 point in pre-market trading today after […]
